<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Authors | Paul Schneider</title>
    <link>https://bitowaqr.github.io/authors/</link>
      <atom:link href="https://bitowaqr.github.io/authors/index.xml" rel="self" type="application/rss+xml" />
    <description>Authors</description>
    <generator>Source Themes Academic (https://sourcethemes.com/academic/)</generator><language>en-us</language><copyright>Â© Paul Schneider 2022 (last update: 18 October 2021)</copyright>
    <image>
      <url>https://bitowaqr.github.io/img/icon-192.png</url>
      <title>Authors</title>
      <link>https://bitowaqr.github.io/authors/</link>
    </image>
    
    <item>
      <title></title>
      <link>https://bitowaqr.github.io/authors/admin/</link>
      <pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate>
      <guid>https://bitowaqr.github.io/authors/admin/</guid>
      <description>&lt;h1 id=&#34;about-me&#34;&gt;about me&lt;/h1&gt;
&lt;p&gt;I am a PhD student in the Wellcome Trust doctoral training centre for public health, economics, and decision science at ScHARR, the University of Sheffield.&lt;/p&gt;
&lt;p&gt;I mainly work on theoretical and methodological issues in the valuation of health (see &lt;a href=&#34;#phdprojects&#34;&gt;discussion papers&lt;/a&gt; below). But I also sometimes build health economic models in R and develop R Shiny interfaces for them  (see &lt;a href=&#34;#rshinyhta&#34;&gt;R and R Shiny for HTA&lt;/a&gt; below).&lt;/p&gt;
&lt;p&gt;My background is in clinical medicine and health sciences. I am a physician by training, and completed a doctoral degree in medicine at the Institute for Health Systems Research, University of Witten/Herdecke, Germany. I also hold a research masters degree in health sciences from Maastricht University, the Netherlands. Before I joined ScHARR in September 2018, I worked on research projects in a range of different areas, including health technology assessment, digital disease surveillance, health service research, clinical drug trials, and global health policy.&lt;/p&gt;
</description>
    </item>
    
  </channel>
</rss>
